
Assessing the safety of inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents
Clinical trials for vaccines and therapies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have predominantly focused on adults thus far. With a few rare exceptions, healthy children and adolescents infected with the virus often present with either asymptomatic or mild manifestations of coronavirus disease 2019 (COVID-19). However, due to the transmission risk that children and adolescents pose as […]
Read more